Maternal and Child Health Practice Questions

Q: Pearl index for contraceptive effectiveness is calculated in terms of which of the following? 1. Pregnancy rate 2. Abortion rate 3. Hundred woman years 4. Thousand woman years Select the correct answer using the code given below:

1 and 3. ***1 and 3*** - The **Pearl Index** is a common method for measuring the **effectiveness of contraception**. - It calculates the number of pregnancies per **100 women-years** of exposure to a particular contraceptive method. *2 and 3* - While abortions can occur in cases of contraceptive failure, the **Pearl Index** specifically focuses on the **pregnancy rate**, not the abortion rate. - The denominator of **hundred woman-years** is correct, but abortion rate is not a direct component of the Pearl Index calculation. *1 only* - The **pregnancy rate** is indeed a key component of the Pearl Index, but it must be expressed in a standardized unit, which is typically **hundred woman-years**. - Simply stating "pregnancy rate" without the context of exposure time is insufficient for the Pearl Index. *1, 2 and 4* - The **Pearl Index** does not directly incorporate the **abortion rate**. - Its standard denomination is **hundred woman-years**, not thousand woman-years.

Q: Which contraceptive method is most effective in preventing sexually transmitted infections?

Male condoms. ***Male condoms*** - **Male condoms** are the most effective method available for preventing the transmission of **STIs**, including HIV, gonorrhea, chlamydia, and syphilis, when used correctly and consistently. - They act as a **physical barrier** that prevents the exchange of bodily fluids and skin-to-skin contact where infections might be present. *Spermicides* - **Spermicides** are chemical substances designed to kill sperm and prevent pregnancy, but they offer **no protection against STIs**. - In fact, some spermicides, especially those containing **nonoxynol-9**, can irritate genital tissues and may even increase the risk of STI transmission by causing micro-abrasions. *Hormonal contraceptives* - **Hormonal contraceptives** (e.g., birth control pills, patches, injections, vaginal rings) are highly effective at preventing pregnancy by inhibiting ovulation. - However, they offer **no protection against STIs** because they do not create a physical barrier to prevent the exchange of infectious bodily fluids or skin contact. *Intrauterine devices* - **Intrauterine devices (IUDs)** are T-shaped devices inserted into the uterus for long-term pregnancy prevention. They are highly effective for contraception. - Similar to hormonal contraceptives, IUDs provide **no protection against STIs**, as they do not block the transmission pathways for infections.

Q: The number of maternal deaths per 100,000 live births is called-

Maternal mortality ratio. ***Maternal mortality ratio*** - This is the standard epidemiological indicator defining the number of **maternal deaths per 100,000 live births**. - It measures the risk of death due to pregnancy in a population. *Maternal mortality rate* - This term is often used interchangeably with maternal mortality ratio, but technically, a **rate usually includes time in the denominator** (e.g., deaths per person-year). - While related to maternal mortality, it's not the precise term for deaths per live births. *Infant mortality rate* - This measures the number of **deaths of infants under one year of age per 1,000 live births**. - It does not specifically refer to deaths of mothers. *Perinatal mortality rate* - This calculates the number of **stillbirths and deaths in the first week of life per 1,000 total births** (live births plus stillbirths). - It focuses on deaths around the time of birth in the infant, not the mother.

Q: Calculate the maternal mortality ratio (MMR) for the year 2023, given the following data: - Total live births: 4,000 - Women who died: 6 (1 due to a road traffic accident (RTA), 1 due to sepsis, 1 due to obstructed labor, 1 due to eclampsia, 1 due to ectopic pregnancy, and 1 due to a snake bite)

100 per 100,000 live births. ***Correct: 100 per 100,000 live births*** - The **maternal mortality ratio (MMR)** includes deaths directly or indirectly due to pregnancy, childbirth, or within 42 days of termination of pregnancy, **excluding accidental or incidental causes**. - In this scenario, **4 maternal deaths** are identified: sepsis (direct), obstructed labor (direct), eclampsia (direct), and ectopic pregnancy (direct). - **Excluded deaths**: RTA and snake bite are **incidental/accidental deaths** not related to pregnancy complications. - **Calculation**: MMR = (4 / 4,000) × 100,000 = **100 per 100,000 live births** *Incorrect: 75 per 100,000 live births* - This would incorrectly count only **3 maternal deaths** instead of 4, suggesting underestimation or exclusion of a valid maternal death (e.g., ectopic pregnancy). - Represents a **miscalculation** that underestimates maternal mortality burden. *Incorrect: 150 per 100,000 live births* - This would incorrectly include **6 deaths** (all deaths including RTA and snake bite), failing to exclude incidental causes. - Including **non-maternal accidental deaths** inflates MMR and misrepresents actual maternal health outcomes. *Incorrect: 125 per 100,000 live births* - This would incorrectly count **5 deaths**, suggesting inclusion of one incidental death (either RTA or snake bite). - Fails to properly identify and exclude **both incidental deaths**, leading to an overestimated ratio.

Q: Given the following data: 500 live births and 9 deaths within the first 7 days, calculate the early neonatal mortality rate.

18 per 1,000 live births. ***18 per 1,000 live births*** - The **early neonatal mortality rate** is calculated as (number of deaths within the first 7 days / total live births) × 1,000. - In this case, (9 deaths / 500 live births) × 1,000 = **18 per 1,000 live births**. *36 per 1,000 live births* - This value would be obtained by incorrectly doubling the correct calculation. - This represents a common calculation error where the result is multiplied by 2 instead of the standard multiplier of 1,000. *24 per 1,000 live births* - This value would be obtained if there were 12 deaths within the first 7 days, which is not the case here. - This option does not reflect the given data of 9 deaths within 500 live births. *50 per 1,000 live births* - This value would be obtained if there were 25 deaths within the first 7 days. - This option significantly overestimates the early neonatal mortality based on the provided data.

Q: The formula with the numerator as maternal deaths and the denominator as women of reproductive age is used to calculate which of the following?

Maternal mortality rate. ***Maternal mortality rate*** - This formula calculates the **maternal mortality rate**, which expresses the risk of dying from pregnancy-related causes among women of reproductive age in a population. - It uses the total number of maternal deaths in the numerator and the total number of **women of reproductive age** (usually 15-49 years) in the denominator, typically multiplied by a constant (e.g., 100,000) to get a per population figure. *Maternal mortality ratio* - The **maternal mortality ratio** uses the number of **live births** (or live births plus stillbirths) in the denominator, not women of reproductive age. - It measures the risk of maternal death per 100,000 live births, reflecting the obstetric risk associated with each pregnancy. *Perinatal mortality rate* - The **perinatal mortality rate** relates to deaths of fetuses and newborns (typically from 22 weeks gestation up to 7 days after birth), not maternal deaths. - Its numerator includes **fetal deaths** and **early neonatal deaths**, and the denominator is usually total births (live births + stillbirths). *Perinatal mortality ratio* - This term is less commonly used as a distinct epidemiological measure; typically, the term **perinatal mortality rate** encompasses both the frequency of perinatal deaths relative to total births. - It does not involve maternal deaths or women of reproductive age in its calculation.

Q: What does JSSK stand for?

Janani Shishu Suraksha Karyakram. ***Janani Shishu Suraksha Karyakram*** - **JSSK** is a program initiated by the Indian government to provide **free healthcare services** to pregnant women and sick neonates. - The acronym stands for **Janani Shishu Suraksha Karyakram**, emphasizing "Karyakram" which means program. *Janani Shishu Swasthya Karyakram* - While "Swasthya" means **health**, it is not the correct word in the official acronym for this government initiative. - The official program focuses on "Suraksha" or **safety/protection** for mother and child during childbirth and infancy. *Janani Shishu Suraksha Kendra* - "Kendra" means **center** and indicates a facility, but the program itself is broader than just a center. - The initiative is a comprehensive "Karyakram" or **program** of services, not merely a physical location. *Janani Shishu Swasthya Kendra* - This option incorrectly combines "Swasthya" (health) and "Kendra" (center), neither of which accurately reflect the full acronym. - The correct acronym uses "Suraksha" (safety/protection) and "Karyakram" (program).

Q: Under the Anaemia Mukt Bharath initiative, mild to moderate anaemia in pregnant women <34 weeks of gestation is treated using:

1-2 IFA tablets daily (depending on severity). ***1-2 IFA tablets daily (depending on severity)*** - The **Anaemia Mukt Bharat (AMB)** guidelines recommend **oral iron and folic acid (IFA)** supplementation as the primary treatment for mild to moderate anaemia in pregnant women <34 weeks gestation. - **Mild anaemia (Hb 10-10.9 g/dL):** 1 IFA tablet daily (100 mg elemental iron + 500 mcg folic acid) - **Moderate anaemia (Hb 7-9.9 g/dL):** 2 IFA tablets twice daily (total 200 mg elemental iron per day) - Oral IFA is safe, cost-effective, and addresses the underlying nutritional deficiency. *IM ferric carboxy maltose (FCM)* - **Intramuscular (IM) iron** formulations like FCM are generally reserved for cases of severe anaemia, malabsorption, or intolerance to oral iron. - For mild to moderate anaemia, IM iron is not the **first-line treatment** under AMB guidelines due to potential injection site reactions and the effectiveness of oral alternatives. *IV iron sucrose for non-compliance with oral tablets* - **Intravenous (IV) iron sucrose** is indicated for specific situations such as severe anaemia (Hb <7 g/dL), significant malabsorption, documented intolerance, or persistent non-compliance with oral iron. - However, for mild to moderate anaemia, efforts are made to ensure compliance with oral treatment before resorting to **parenteral iron**, particularly given its higher cost and need for administration in a healthcare setting. *2 iron and folic acid tablets OD+IV iron sucrose* - Combining **oral iron tablets with IV iron sucrose** is not recommended for mild to moderate anaemia under AMB guidelines. - This approach would be considered **overtreatment** for mild to moderate anaemia in the absence of severe anaemia or documented failure of oral therapy despite good compliance.

Q: A resource-limited setting shows high rates of congenital syphilis despite antenatal screening programs. Lab records show stock-outs and delayed results. Which integrated approach is most cost-effective?

Implementation of point-of-care testing with same-day treatment. ***Implementation of point-of-care testing with same-day treatment*** - This approach directly addresses **stock-outs** and **delayed results** by providing immediate diagnosis and treatment, significantly reducing the window for mother-to-child transmission. - **Point-of-care testing (POCT)** eliminates the need for complex lab infrastructure and transport, making it highly cost-effective and efficient in resource-limited settings. *Enhanced partner notification only* - While important for controlling syphilis spread, **partner notification alone** does not solve the fundamental issues of delayed diagnosis and treatment for the pregnant woman. - It would not prevent congenital syphilis in cases where the mother's infection is already established and untreated due to diagnostic delays. *Universal prophylactic treatment* - Administering **universal prophylactic treatment** without a confirmed diagnosis is not cost-effective due to unnecessary drug use, potential for antibiotic resistance, and wastage of resources. - It would also not address the underlying systemic issues of screening program failures, only providing a broad, untargeted intervention. *Increased lab capacity with result tracking system* - This option addresses **delayed results** and **stock-outs** but requires significant financial investment in infrastructure, equipment, and personnel, which may not be feasible or as rapid in implementation as POCT. - Even with increased capacity, transport of samples and results can still introduce delays, and the cost-benefit might be lower compared to immediate POCT.

Q: 'Cafeteria approach' is related with:

Contraception. ***Contraception*** - The **cafeteria approach** in contraception refers to offering a wide variety of **contraceptive methods** to individuals, allowing them to choose the option that best suits their needs, preferences, and circumstances. - This approach promotes **informed choice** and adherence by recognizing that no single contraceptive method is ideal for everyone. *Diet program* - While diet programs involve choices, the term **cafeteria approach** is not specifically or exclusively associated with the methodology of diet selection. - Diet programs typically focus on dietary guidelines or meal plans rather than a broad offering of methods. *National vector borne disease control programme* - This program focuses on managing and preventing **vector-borne diseases** through public health interventions, which does not involve individual "choices" in a cafeteria-style manner. - Its strategies include surveillance, vector control, and case management, without a direct "cafeteria approach" element. *Child and maternal health* - This broad field encompasses various health interventions, but the **cafeteria approach** is not a specific methodology used to describe comprehensive child and maternal health services. - While choices are involved in healthcare, this term is not standard in this context.

Question 1

Pearl index for contraceptive effectiveness is calculated in terms of which of the following?

1. Pregnancy rate
2. Abortion rate
3. Hundred woman years
4. Thousand woman years

Select the correct answer using the code given below:

Accepted Answer

1 and 3

Answer

2 and 3

Answer

1 only

Answer

1, 2 and 4

Question 2

Which contraceptive method is most effective in preventing sexually transmitted infections?

Accepted Answer

Male condoms

Answer

Spermicides

Answer

Hormonal contraceptives

Answer

Intrauterine devices

Question 3

The number of maternal deaths per 100,000 live births is called-

Accepted Answer

Maternal mortality ratio

Answer

Maternal mortality rate

Answer

Infant mortality rate

Answer

Perinatal mortality rate

Question 4

Calculate the maternal mortality ratio (MMR) for the year 2023, given the following data:

- Total live births: 4,000
- Women who died: 6 (1 due to a road traffic accident (RTA), 1 due to sepsis, 1 due to obstructed labor, 1 due to eclampsia, 1 due to ectopic pregnancy, and 1 due to a snake bite)

Accepted Answer

100 per 100,000 live births

Answer

75 per 100,000 live births

Answer

150 per 100,000 live births

Answer

125 per 100,000 live births

Question 5

Given the following data: 500 live births and 9 deaths within the first 7 days, calculate the early neonatal mortality rate.

Accepted Answer

18 per 1,000 live births

Answer

36 per 1,000 live births

Answer

24 per 1,000 live births

Answer

50 per 1,000 live births

Question 6

The formula with the numerator as maternal deaths and the denominator as women of reproductive age is used to calculate which of the following?

Accepted Answer

Maternal mortality rate

Answer

Maternal mortality ratio

Answer

Perinatal mortality rate

Answer

Perinatal mortality ratio

Question 7

What does JSSK stand for?

Accepted Answer

Janani Shishu Suraksha Karyakram

Answer

Janani Shishu Swasthya Karyakram

Answer

Janani Shishu Suraksha Kendra

Answer

Janani Shishu Swasthya Kendra

Question 8

Under the Anaemia Mukt Bharath initiative, mild to moderate anaemia in pregnant women <34 weeks of gestation is treated using:

Accepted Answer

1-2 IFA tablets daily (depending on severity)

Answer

IM ferric carboxy maltose (FCM)

Answer

IV iron sucrose for non-compliance with oral tablets

Answer

2 iron and folic acid tablets OD+IV iron sucrose

Question 9

A resource-limited setting shows high rates of congenital syphilis despite antenatal screening programs. Lab records show stock-outs and delayed results. Which integrated approach is most cost-effective?

Accepted Answer

Implementation of point-of-care testing with same-day treatment

Answer

Enhanced partner notification only

Answer

Universal prophylactic treatment

Answer

Increased lab capacity with result tracking system

Question 10

'Cafeteria approach' is related with:

Accepted Answer

Contraception

Answer

Diet program

Answer

National vector borne disease control programme

Answer

Child and maternal health

Maternal and Child Health — MCQs

Maternal and Child Health — MCQs

On this page

Practice by Chapter

Want unlimited practice?